1. Home
  2. INDP vs GMM Comparison

INDP vs GMM Comparison

Compare INDP & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • GMM
  • Stock Information
  • Founded
  • INDP 2000
  • GMM 2017
  • Country
  • INDP United States
  • GMM China
  • Employees
  • INDP N/A
  • GMM N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • GMM
  • Sector
  • INDP Health Care
  • GMM
  • Exchange
  • INDP Nasdaq
  • GMM Nasdaq
  • Market Cap
  • INDP 10.2M
  • GMM 9.8M
  • IPO Year
  • INDP N/A
  • GMM 2023
  • Fundamental
  • Price
  • INDP $0.84
  • GMM $3.87
  • Analyst Decision
  • INDP Strong Buy
  • GMM
  • Analyst Count
  • INDP 2
  • GMM 0
  • Target Price
  • INDP $8.50
  • GMM N/A
  • AVG Volume (30 Days)
  • INDP 25.3K
  • GMM 144.9K
  • Earning Date
  • INDP 03-12-2025
  • GMM 01-29-2025
  • Dividend Yield
  • INDP N/A
  • GMM N/A
  • EPS Growth
  • INDP N/A
  • GMM 62.17
  • EPS
  • INDP N/A
  • GMM 6.37
  • Revenue
  • INDP N/A
  • GMM $41,360,953.00
  • Revenue This Year
  • INDP N/A
  • GMM N/A
  • Revenue Next Year
  • INDP N/A
  • GMM N/A
  • P/E Ratio
  • INDP N/A
  • GMM $0.61
  • Revenue Growth
  • INDP N/A
  • GMM 53.82
  • 52 Week Low
  • INDP $0.81
  • GMM $0.21
  • 52 Week High
  • INDP $3.10
  • GMM $4.97
  • Technical
  • Relative Strength Index (RSI)
  • INDP 39.07
  • GMM 54.98
  • Support Level
  • INDP $0.86
  • GMM $3.55
  • Resistance Level
  • INDP $1.06
  • GMM $4.16
  • Average True Range (ATR)
  • INDP 0.08
  • GMM 0.58
  • MACD
  • INDP 0.00
  • GMM -0.09
  • Stochastic Oscillator
  • INDP 12.80
  • GMM 32.02

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd, formerly Global Mofy Metaverse Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: